Evaluation on Bioactive Secondary Metabolites from Fingerroot (Boesenbergia rotunda) as a Potent α-Glucosidase Inhibitor: In silico Study
In silico Study
Downloads
Fingerroot (Boesenbergia rotunda) is a medicinal plant that has been reported to have anti-diabetic properties. However, the mechanism of action and the active compounds responsible for this effect are not well understood. In this study, we performed molecular docking study of isolated compound from fingerroot against N-terminal-human intestinal maltase-glucoamylase, one class of α-glucosidase. Inhibiting enzymatic activity of alpha glucosidase could potentially control sugar levels. In addition to panduratin A showing moderate inhibition activity against N-terminal-human intestinal maltase-glucoamylase.
O. Ongwisespaiboon and W. Jiraungkoorskul, “Fingerroot, Boesenbergia rotunda and its aphrodisiac activity,” Pharmacogn Rev, vol. 11, no. 21, p. 27, 2017, doi: 10.4103/phrev.phrev_50_16.
S. Thomya, M. Wongkaew, W. Bundithya, C. Lumsangkul, P. Jantrawut, and S. R. Sommano, “Relationship between Phenotypes and Chemical Profiling of Boesenbergia rotunda Collected from Different Habitats of Northern Thailand,” Agronomy, vol. 13, no. 6, p. 1435, May 2023, doi: 10.3390/agronomy13061435.
T. Eng-Chong et al., “Boesenbergia rotunda : From Ethnomedicine to Drug Discovery,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, pp. 1–25, 2012, doi: 10.1155/2012/473637.
S. Saah, D. Siriwan, and P. Trisonthi, “Biological activities of Boesenbergia rotunda parts and extracting solvents in promoting osteogenic differentiation of pre-osteoblasts,” Food Biosci, vol. 41, p. 101011, Jun. 2021, doi: 10.1016/j.fbio.2021.101011.
S. Bhamarapravati, S. Juthapruth, W. Mahachai, and G. Mahady, “Antibacterial activity of Boesenbergia rotunda (L.) Mansf. and Myristica fragrans Houtt. against Helicobacter pylori.”
N. Chatsumpun, B. Sritularak, and K. Likhitwitayawuid, “New Biflavonoids with α-Glucosidase and Pancreatic Lipase Inhibitory Activities from Boesenbergia rotunda,” Molecules, vol. 22, no. 11, p. 1862, Oct. 2017, doi: 10.3390/molecules22111862.
S. Y. Liew et al., “Natural alpha-glucosidase inhibitors from selected medicinal plants in Malaysia,” J Natl Sci Found, vol. 51, no. 2, Jun. 2023, doi: 10.4038/jnsfsr.v51i2.11177.
F. A. Van de Laar, P. L. Lucassen, R. P. Akkermans, E. H. Van de Lisdonk, G. E. Rutten, and C. Van Weel, “Alpha-glucosidase inhibitors for type 2 diabetes mellitus,” Cochrane Database of Systematic Reviews, vol. 2009, no. 1, Apr. 2005, doi: 10.1002/14651858.CD003639.pub2.
S. Escandón-Rivera, M. González-Andrade, R. Bye, E. Linares, A. Navarrete, and R. Mata, “Correction to α-Glucosidase Inhibitors from Brickellia cavanillesii,” J Nat Prod, vol. 80, no. 1, pp. 233–233, Jan. 2017, doi: 10.1021/acs.jnatprod.6b01120.
P. M. Danby and S. G. Withers, “Advances in Enzymatic Glycoside Synthesis,” ACS Chem Biol, vol. 11, no. 7, pp. 1784–1794, Jul. 2016, doi: 10.1021/acschembio.6b00340.
K. Jones et al., “Mapping the intestinal alpha-glucogenic enzyme specificities of starch digesting maltase-glucoamylase and sucrase-isomaltase,” Bioorg Med Chem, vol. 19, no. 13, pp. 3929–3934, Jul. 2011, doi: 10.1016/j.bmc.2011.05.033.
S. Nakamura, K. Takahira, G. Tanabe, O. Muraoka, and I. Nakanishi, “Homology Modeling of Human Alpha-Glucosidase Catalytic Domains and SAR Study of Salacinol Derivatives,” Open J Med Chem, vol. 02, no. 03, pp. 50–60, 2012, doi: 10.4236/ojmc.2012.23007.
B.-H. Lee, R. Quezada-Calvillo, B. L. Nichols, D. R. Rose, and B. R. Hamaker, “Inhibition of Maltase-Glucoamylase Activity to Hydrolyze α-1,4 Linkages by the Presence of Undigested Sucrose,” J Pediatr Gastroenterol Nutr, vol. 55, no. Supplement 2, pp. S45–S47, Nov. 2012, doi: 10.1097/01.mpg.0000421415.95751.f7.
H. Kashtoh and K.-H. Baek, “Recent Updates on Phytoconstituent Alpha-Glucosidase Inhibitors: An Approach towards the Treatment of Type Two Diabetes,” Plants, vol. 11, no. 20, p. 2722, Oct. 2022, doi: 10.3390/plants11202722.
S. Mohan, R. Eskandari, and B. M. Pinto, “Naturally Occurring Sulfonium-Ion Glucosidase Inhibitors and Their Derivatives: A Promising Class of Potential Antidiabetic Agents,” Acc Chem Res, vol. 47, no. 1, pp. 211–225, Jan. 2014, doi: 10.1021/ar400132g.
H. Matsuda, T. Morikawa, and M. Yoshikawa, “Antidiabetogenic constituents from several natural medicines,” Pure and Applied Chemistry, vol. 74, no. 7, pp. 1301–1308, Jan. 2002, doi: 10.1351/pac200274071301.
S. Ekins, J. Mestres, and B. Testa, “In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling,” Br J Pharmacol, vol. 152, no. 1, pp. 9–20, Sep. 2007, doi: 10.1038/sj.bjp.0707305.
J. Fan, A. Fu, and L. Zhang, “Progress in molecular docking,” Quantitative Biology, vol. 7, no. 2, pp. 83–89, Jun. 2019, doi: 10.1007/s40484-019-0172-y.
Copyright (c) 2023 Journal of Bio-molecule Research And Engineering
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
COPYRIGHT NOTICE
1. By submitting the article toJournal of Bio-Molecule Research and Engineering [JBIOME], the author has agreed to transfer some of the copyrights to the publisher of the research chemistry journal, Universitas Airlangga, indicated in the Copyright Transfer Agreement.
2. Authors still retain significant rights to use and share their own published articles for non-commercial purposes subject to Creative Commons Attribution-NonComercial-ShareALike 4.0 International License
3. All publications (printed/electronic) are open access for educational purposes, research, library, and other non-commercial purposes. Besides the purposes mentioned above, the editorial board is not responsible for copyright violations.
